William White Biography and Net Worth

Director of Disc Medicine

Bill White is the Chief Financial Officer and Head of Corporate Development at Akero Therapeutics. Prior to joining Akero, Bill spent 18 years as a life-science-focused investment banker. He was most recently Head of U.S. Life Sciences Investment Banking at Deutsche Bank, and previously worked at Goldman Sachs and Citigroup. Prior to his time on Wall Street, Bill was an attorney at Sullivan & Cromwell and a Law Clerk to the Honorable Kimba M. Wood of the Southern District of New York. He holds an AB from Princeton, a MPP from Harvard, and a JD from Columbia.

What is William Richard White's net worth?: The estimated net worth of William Richard White is at least $5.42 million as of September 11th, 2025. Mr. White owns 57,752 shares of Disc Medicine stock worth more than $5,416,560 as of December 5th. This net worth evaluation does not reflect any other assets that Mr. White may own. Learn More about William Richard White's net worth.
How do I contact William Richard White?: The corporate mailing address for Mr. White and other Disc Medicine executives is 297 Boston Post Road #248, Wayland MA, 01778. Disc Medicine can also be reached via phone at 617-401-4400 and via email at [email protected]. Learn More on William Richard White's contact information.
Has William Richard White been buying or selling shares of Disc Medicine?: William Richard White has not been actively trading shares of Disc Medicine over the course of the past ninety days. Most recently, William Richard White sold 1,957 shares of the business's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $64.63, for a transaction totalling $126,480.91. Learn More on William Richard White's trading history.
Who are Disc Medicine's active insiders?: Disc Medicine's insider roster includes Mona Ashiya (Director), Kevin Bitterman (Director), Joanne Bryce (CFO), Jean Franchi (CFO), Rahul Khara (Insider), Brian Macdonald (Insider), John Quisel (CEO), William Savage (Insider), Pamela Stephenson (Insider), William White (Director), and Jonathan Yu (COO). Learn More on Disc Medicine's active insiders.
Are insiders buying or selling shares of Disc Medicine?: During the last year, insiders at the sold shares 36 times. They sold a total of 773,084 shares worth more than $48,364,938.08. The most recent insider tranaction occured on November, 11th when COO Jonathan Yen-Wen Yu sold 30,000 shares worth more than $2,541,000.00. Insiders at Disc Medicine own 3.6% of the company. Learn More about insider trades at Disc Medicine.
Information on this page was last updated on 11/11/2025.

William Richard White Insider Trading History at Disc Medicine

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/2/2024	Sell	1,957	$64.63	$126,480.91
11/4/2024	Sell	7,136	$58.61	$418,240.96
11/1/2024	Sell	201	$46.37	$9,320.37
10/1/2024	Sell	201	$51.31	$10,313.31
8/1/2024	Sell	201	$43.44	$8,731.44
4/11/2024	Sell	2,560	$31.80	$81,408.00

William Richard White Buying and Selling Activity at Disc Medicine

Disc Medicine Company Overview

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $93.79

$91.22

$94.58

50 Day Range

MA: $82.90

$65.06

$94.11

2 Week Range

Now: $93.79

$30.82

$97.11

Volume

280,041 shs

Average Volume

539,480 shs

Market Capitalization

$3.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87